|
MFAP3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.28190000001383E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.52089999985827E-07 |
| Normal-vs-Stage2 |
4.737200E-03 |
| Normal-vs-Stage3 |
7.177200E-03 |
| Normal-vs-Stage4 |
1.393830E-01 |
| Stage1-vs-Stage2 |
9.744200E-01 |
| Stage1-vs-Stage3 |
9.308000E-02 |
| Stage1-vs-Stage4 |
5.638300E-03 |
| Stage2-vs-Stage3 |
3.137000E-01 |
| Stage2-vs-Stage4 |
8.112400E-02 |
| Stage3-vs-Stage4 |
2.873400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.1986999999597E-07 |
| Normal-vs-AfricanAmerican |
8.328800E-01 |
| Normal-vs-Asian |
2.116800E-01 |
| Caucasian-vs-AfricanAmerican |
2.022600E-03 |
| Caucasian-vs-Asian |
6.989200E-01 |
| AfricanAmerican-vs-Asian |
3.601600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.56650000000736E-05 |
| Normal-vs-Female |
7.56299999999932E-05 |
| Male-vs-Female |
8.862600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.123800E-02 |
| Normal-vs-Age(41-60Yrs) |
1.18920000002909E-06 |
| Normal-vs-Age(61-80Yrs) |
5.773400E-04 |
| Normal-vs-Age(81-100Yrs) |
1.244790E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.804200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.128000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.767000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.561900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.845000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.842800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.162200E-03 |
| Normal-vs-Grade 2 |
7.57450000499205E-08 |
| Normal-vs-Grade 3 |
6.388500E-04 |
| Normal-vs-Grade 4 |
5.641400E-01 |
| Grade 1-vs-Grade 2 |
2.886600E-01 |
| Grade 1-vs-Grade 3 |
2.379600E-02 |
| Grade 1-vs-Grade 4 |
2.115200E-03 |
| Grade 2-vs-Grade 3 |
1.330400E-02 |
| Grade 2-vs-Grade 4 |
7.5544000000094E-05 |
| Grade 3-vs-Grade 4 |
2.161700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.33999486454195E-11 |
| Normal-vs-ccB subtype |
5.623500E-03 |
| ccA subtype-vs-ccB subtype |
6.43659999999269E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.81432999999398E-05 |
| Normal-vs-N1 |
7.366200E-01 |
| N0-vs-N1 |
1.433040E-01 |
|
|
